Jude Moutchia, MD, MPH, MS

Data Scientist, Pulmonary Vascular Disease Program, University of Pennsylvania

“Epidemiology and Treatment Heterogeneity of PAH in the U.S.”

Jake Brenner, MD, PhD

Assistant Professor & Attending Physician, Departments of Medicine and Pharmacology, University of Pennsylvania

“DNA-loaded lipid nanoparticles (DNA-LNPs) for pulmonary hypertension.”

Ripla Arora, PhD

Developmental Geneticist and Associate Professor, Michigan State University

“Mechanisms underlying developmental lung disease in a TBX4 syndrome model”

Kate Enzer, MD

Assistant Professor, Pediatrics, University of Colorado

“Pulmonary Ventilation and Perfusion with Electrical Impedance Tomography”

Lindsay “Shelley” Forbes, MD

Instructor, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus

“Mediators of Right Ventricular Dysfunction Among Patients with PH-COPD”

Neil Kelly, MD

Physician-Scientist, Division of Cardiology, University of Pittsburgh and Veterans Affairs, Pittsburgh Healthcare System

“Pollution-associated metabolites as drivers of pulmonary hypertension in populations with health disparities”

Sanjeev Datar, MD

Professor, Pediatrics Associate Director, Physician-Scientist Career Development Program (PSCDP), The Regents of the University of California, San Francisco

“A Large Animal Model of Heritable PAH: Generating BMPR2 Heterozygous Sheep”

Aimee M. Layton, PhD

Associate Professor of Applied Physiology (in Pediatrics), Director of the Pediatric Cardiology Cardiopulmonary Exercise Laboratory, Columbia University Medical Center

“Telerehabilitation to Improve Fear and Anxiety in Adolescents with PAH”

Roopa Siddaiah, MD

Assistant Professor, Pediatric Pulmonology, Penn State College of Medicine

“Predictors of Pulmonary Hypertension Associated Bronchopulmonary Dysplasia”

Ke Yuan, PhD

Associate Scientific Researcher and Assistant Professor of Pediatrics, Harvard Medical School, Boston Children’s Hospital Division of Pulmonary Medicine

“Perivascular cells contribute to flow-included PH”

Adam Andruska, MD

Instructor, Department of Medicine, Pulmonary, Allergy, and Critical Care, Stanford University School of Medicine

“T-cell vascular signaling as a therapeutic target for PAH”

Csaba Galambos, MD, PhD

Director, Pediatric Pulmonary Research and Investigator, Pediatric Heart Lung Center, Children’s Hospital Colorado

“The role of bronchial circulation in pulmonary hypertension”

Catherine Simpson, MD

Assistant Professor, Pulmonary and Critical Care Medicine, Johns Hopkins University

“Compartment-specific kynurenine pathway metabolism in PAH”

Paul Critser, MD, PhD

Assistant Professor, Pediatrics Children’s Hospital Medical Center, Cincinnati

“Pulmonary vascular development in BPD associated PH”

Vineet Agrawal, MD

Instructor, Division of Cardiovascular Medicine, Vanderbilt University Medical Center (VUMC)

“TGF-beta Receptor 3 as a Novel Mediator of Endothelial Metabolism in PAH”

Rahul Kumar, PhD

Associate Professional Researcher, Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco

“Crosstalk Between Bone Marrow Compartment and Inflamed Lungs in Hypoxic Pulmonary Hypertension”

Learn more in the article “Research Fellow to Study How Inflammation Contributes to PH.”

Olivier Boucherat, PhD

Professor, Pneumology, L’Université Laval

b“Forkhead-box FOX) Transcription Factors in Pulmonary Arterial Hypertension”

Nadine Al-Naamani, MD, MS

Instructor of Medicine, University of Pennsylvania

“Effect of obesity on treatment response in pulmonary arterial hypertension”

Jason Boehme, MD

Assistant Professor of Pediatrics, University of California, San Francisco

“Pulmonary Vascular Smooth Muscle Metabolic Reprogramming in Congenital Heart Disease”

Ke Yuan, PhD

Associate Scientific Researcher and Assistant Professor of Pediatrics, Harvard Medical School, Boston Children’s Hospital Division of Pulmonary Medicine

“SDF1 Signaling: A Master Regulator of Mural Cell-Dependent Vascular Remodeling in PAH”

Soban Umar, MD

Assistant Professor-in-Residence, University of California, Los Angeles

“miR-125b as a Novel Therapeutic Target in Pulmonary Hypertension Associated with Pulmonary Fibrosis”

Michael L. O’Byrne, MD, MSCE

London A. Lotarski Pediatric PH Research & Mentoring, Assistant Professor – CE (Pediatrics), The Children’s Hospital of Philadelphia

“Multidimensional evaluation of health-related quality of life in pediatric pulmonary hypertension”

Zhiyu Dai, PhD

Research Assistant Professor, Northwestern University, Ann & Robert H. Lurie Children’s Hospital of Chicago

“Role of Endothelial-to-Mesenchymal Transition on Vascular Fibrosis in PAH”

Andrew John Sweatt, MD

Instructor of Medicine, Stanford University

“Deep immunophenotyping of pulmonary arterial hypertension by unsupervised machine learning”

Nadine Al-Naamani, MD, MS

Instructor of Medicine, University of Pennsylvania

“Effect of obesity on treatment response in pulmonary arterial hypertension”

Kazuyo Kegan, PhD

Assistant Professor, Anesthesiology and Critical Care Medicine, Johns Hopkins University

“Illuminating AMPK function in crosstalk between Insulin Resistance and Pulmonary Hypertension”

Farbod Rahaghi, MD, PhD

Instructor, Pulmonary and Critical Care, Brigham and Women’s Hospital

“CT Imaging Markers of Pulmonary Arterial and Venous Remodeling in Pulmonary Hypertension”

Meghan Bernier, MD

T32 Research Fellow, The Johns Hopkins Hospital

“LOX-1: A Therapeutic Target for Pulmonary Hypertension in Lung Endothelium”

Rachel Hopper, MD

Attending Physician, The Children’s Hospital of Philadelphia

“Comprehensive Analysis of Persistent Pulmonary Hypertension in Congenital Diaphragmatic Hernia”

Sheila Krishnan, DO

Pulmonary and Critical Care Fellow, Indiana University

“Hypoxia-dependent Epigenetic Modifications in the Pulmonary Vasculature”

Olivier Boucherat, PhD

Professor, Pneumology, L’Université Laval

“Forkhead-box (FOX) transcription factors in Pulmonary Arterial Hypertension”